Search - tctmd.com

Displaying 721 - 740 of 2689

Sort: Relevancy | Date

Presentation NY Valves 2024

Atrial FMR: The Heart Failure Perspective – Epidemiology and Medical Management

Presenter: Akshay Desai

June 05, 2024

Presentation NY Valves 2024

Resolution of Chronic Respiratory Failure and Transfusion-Dependent Anemia After Percutaneous Mitral Paravalvular Leak Closure Following Recent Surgical Mitral Valve Replacement

Presenter: Rahul Sawhney

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

Presenter: Nirat Beohar

June 05, 2024

Presentation ACC 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presenter: Martin S. Maron

April 08, 2024

Presentation ACC 2024

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Presenter: James L. Januzzi Jr

April 08, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

Presentation ACC 2024

Principal Results from the RELIEVE-HF Trial

Presenter: Gregg W. Stone

April 06, 2024

MicroRNA in Cardiac Transplantation: Biomarkers With Therapeutic Potential

Presentation THT 2024

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Presenter: Palak Shah

March 06, 2024

Presentation THT 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presenter: Dawn E. Bowles

March 06, 2024

Presentation THT 2024

Designing a Bionic Heart

Presenter: Ellen Roche

March 06, 2024

Presentation THT 2024

3D-Bioprinted Human Tissue and the Path Towards Clinical Translation

Presenter: Adam W. Feinberg

March 06, 2024

Presentation THT 2024

Xeno-Transplant: Where Do We Go From Here?

Presenter: Richard Pierson

March 06, 2024

Presentation THT 2024

Xeno-Transplant: How We Got Here

Presenter: Albert J. Hicks

March 06, 2024

Presentation THT 2024

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

Presenter: Eduardo Rame

March 06, 2024

Presentation THT 2024

DCD with Organ Care System (OCS) versus DCD Normothermic Regional Perfusion (NRP)

Presenter: Nader Moazami

March 06, 2024

Presentation THT 2024

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Presenter: William T. Abraham

March 06, 2024

Presentation THT 2024

Results With Warm Preservation

Presenter: Duc Thinh Pham

March 06, 2024

Presentation THT 2024

Results With Cold Oxygenated Preservation

Presenter: Scott Silvestry

March 06, 2024

Presentation THT 2024

Temperature Controlled Devices

Presenter: Andreas Zuckermann

March 06, 2024

Presentation THT 2024

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Presenter: Maria Rosa Costanzo

March 06, 2024

Advertisement

Atrial FMR: The Heart Failure Perspective – Epidemiology and Medical Management

Resolution of Chronic Respiratory Failure and Transfusion-Dependent Anemia After Percutaneous Mitral Paravalvular Leak Closure Following Recent Surgical Mitral Valve Replacement

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Main Results From The Step-hfpef Dm Trial

Principal Results from the RELIEVE-HF Trial

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Ex Vivo Gene Therapy in Cardiac Allografts

Designing a Bionic Heart

3D-Bioprinted Human Tissue and the Path Towards Clinical Translation

Xeno-Transplant: Where Do We Go From Here?

Xeno-Transplant: How We Got Here

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

DCD with Organ Care System (OCS) versus DCD Normothermic Regional Perfusion (NRP)

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Results With Warm Preservation

Results With Cold Oxygenated Preservation

Temperature Controlled Devices

Inclusion Criteria and Endpoints for Trials of Devices to Treat ADHF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content